Vascular endocan is preferentially expressed in tumor endothelium.
about
Glycoconjugates and related molecules in human vascular endothelial cellsHCV Tumor Promoting Effect Is Dependent on Host Genetic BackgroundLiver sinusoidal endothelium: a microenvironment-dependent differentiation program in rat including the novel junctional protein liver endothelial differentiation-associated protein-1Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.Endothelium-dependent coronary vasodilatation requires NADPH oxidase-derived reactive oxygen species.Identification of genes and pathways involved in retinal neovascularization by microarray analysis of two animal models of retinal angiogenesisUpregulation of endocan by Epstein-Barr virus latent membrane protein 1 and its clinical significance in nasopharyngeal carcinoma.The non glycanated endocan polypeptide slows tumor growth by inducing stromal inflammatory reaction.Are there new approaches for diagnosis, therapy guidance and outcome prediction of sepsis?Endocan: A new marker for cancer and a target for cancer therapy.Genome-wide screening of copy number alterations and LOH events in renal cell carcinomas and integration with gene expression profileEndocan-expressing microvessel density as a prognostic factor for survival in human gastric cancer.Expressions of Endocan in Patients with Meningiomas and GliomasPlasma endocan level and prognosis of immunoglobulin A nephropathy.Correlation between expression and differentiation of endocan in colorectal cancer.Endocan immunoreactivity in the mouse brain: method for identifying nonfunctional blood vessels.Serum endocan as a novel prognostic biomarker in patients with hepatocellular carcinoma.Serum endocan levels before and after surgery on low-grade gliomas.Markers for sepsis diagnosis in the forensic setting: state of the art.Endocan: a new molecule playing a role in the development of hypertension and chronic kidney disease?Endocan: a novel circulating proteoglycan.Endocan reduces the malign grade of gastric cancer cells by regulating associated protein expression.Endocan and Non-Dipping Circadian Pattern in Newly Diagnosed Essential Hypertension.Clinicopathological correlation of endocan expression and survival in epithelial ovarian cancer.Immunolocalization of endocan during the endothelial-mesenchymal transition process.Endocan in cancers: a lesson from a circulating dermatan sulfate proteoglycan.Enhanced T cell transmigration across the murine liver sinusoidal endothelium is mediated by transcytosis and surface presentation of chemokines.Diagnostic and prognostic values of endothelial-cell-specific molecule-1 with malignant pleural effusions in patients with non-small cell lung cancer.Endocan as an early biomarker of severity in patients with acute respiratory distress syndromeEndocan, a new invasion and angiogenesis marker of pituitary adenomas.Endocan silencing induces programmed cell death in hepatocarcinoma.Elevated serum levels of endocan in patients with psoriasis vulgaris: correlations with cardiovascular risk and activity of disease.Serum endocan levels in endometrial and ovarian cancers.Dopamine agonist resistance-related endocan promotes angiogenesis and cells viability of prolactinomas.Glycated serum albumin stimulates expression of endothelial cell specific molecule-1 in human umbilical vein endothelial cells: Implication in diabetes mediated endothelial dysfunction.Over-expression of the Endocan gene in endothelial cells from hepatocellular carcinoma is associated with angiogenesis and tumour invasion.Endocan in hypertension and cardiovascular disease.Endocan, sepsis, pneumonia, and acute respiratory distress syndromeEndocan Measurement for Active Behçet Disease
P2860
Q27008374-2C82318C-B9E4-4C43-AE53-C5869C52BF6CQ27488251-F5789114-B9E3-4E47-961C-C1F750EEE2DFQ28576015-8B228951-E31D-4025-BA8B-4488B148E8DFQ30366990-465EED3E-D6B1-4039-B79E-FDB87F30DFDCQ30496168-2396BAE9-F57C-471C-BD26-37C38E35E69DQ33845347-0A4A3164-DDDB-478E-8339-06F940360579Q35067738-16220903-3C7D-4C89-BD0D-2709B1F039ABQ35550081-36B4A5D4-5C84-4D90-AEF9-0883804258CAQ35622257-1791365D-5190-4554-96A6-13864F889E76Q35681482-C84820F1-8501-40B8-BCC2-E18BE876BD52Q36477174-97183C01-0B9B-4C2A-AF44-B52F56A6B62AQ37012393-1DA2BB18-BB79-4552-90B3-C7A847D58BE3Q37162853-BBCAF03F-38B9-4BAE-BE8F-6384D83E17D5Q37260183-823B547F-32BC-41BC-BE1B-86EB9903F9ABQ37316926-8F139B69-44BF-448B-AEED-F8389E9BC267Q37341628-AE1F050C-5035-4BBA-8946-9502B41FAB7AQ37657319-CD1FA69A-0D9E-4C67-BDB2-E19BF90FFABAQ37724813-A919F919-E954-4C3B-BFCB-D8C6E8B356CDQ38207964-BD71E781-5369-40A2-80BE-A9CFB48E0443Q38265707-87AEAA29-8F68-42C7-B55C-F4C2178BCADBQ38299725-59732537-2BAD-4C6C-8A20-FE3CBE1447F5Q38745168-3DF15DB1-1D7F-41B6-B927-2B1A2831F7ADQ38797262-C3FA8A0C-AF4D-43EC-912F-87D6BF3B74E1Q38984247-2A178EFC-AFE3-4CFA-800B-2D61D9036808Q39421834-7D85946A-0DF1-4C4D-8FC6-8033D85BB1BEQ39431959-DFB171F3-DBAB-42C8-B6C5-8460AA0F4ACFQ39951498-9640F4F6-08CF-4D1A-B571-DA895B7921BFQ41472390-E539AFFA-0121-4E0D-94B8-03D87A56144CQ41546659-3C19F386-D4AE-4B3B-ACF5-B1CB590BDBC0Q46843616-253B91E3-BB72-457F-A220-302F30F1B687Q47139612-21B346D3-B151-40FE-8AEC-EEA97B504FE2Q47928951-E90E5C3D-0C5E-467B-9D25-73BB469E65F0Q47982714-7D599767-730D-4BB7-9FE3-7D2A5CF40C30Q53246001-7C0DF3F5-4E01-4320-8334-FFF0C0E09440Q53510307-C8062AB6-C439-459B-83E0-B71F39D48B94Q54425814-1DE7B726-0715-45A9-B15D-77F35A562170Q54456960-613B9FDD-3E59-4D03-A3E2-672A0256B9AAQ58113472-F349C5F9-D5B0-49BF-BDBE-CA9D7C4B0787Q58133817-10297153-D237-4764-8932-DA2139C482B2
P2860
Vascular endocan is preferentially expressed in tumor endothelium.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Vascular endocan is preferentially expressed in tumor endothelium.
@en
type
label
Vascular endocan is preferentially expressed in tumor endothelium.
@en
prefLabel
Vascular endocan is preferentially expressed in tumor endothelium.
@en
P2093
P1476
Vascular endocan is preferentially expressed in tumor endothelium.
@en
P2093
Kiichiro Yano
Md Ruhul Abid
Shu-Ching Shih
William C Aird
Xianjin Yi
P304
P356
10.1016/J.MVR.2006.05.010
P577
2006-09-07T00:00:00Z